Sequence, genomic organization, and chromosomal location of the mouse Müllerian-inhibiting substance type II receptor gene
- PMID: 9299437
- DOI: 10.1006/bbrc.1997.7224
Sequence, genomic organization, and chromosomal location of the mouse Müllerian-inhibiting substance type II receptor gene
Abstract
We have determined the sequence and structure of the mouse Müllerian-inhibiting substance (MIS) type II receptor gene. Sequence comparisons demonstrate that the mouse, rat, rabbit, and human MIS type II receptors are highly conserved. The mouse MIS type II receptor gene is encoded by 11 exons and spans approximately 9-kb. Only half of the intron/exon boundaries of its kinase domain are conserved in comparison to the kinase domain of the related activin type II receptor. Whereas the activin type II receptor gene contains large introns (> 40-kb), the largest intron of the MIS type II receptor gene is only 4.3-kb. The MIS type II receptor gene (Amhr) is closely linked to Hoxc on mouse chromosome 15. Knowledge of the sequence and genomic structure of Amhr provides important information for the genetic manipulation of the Amhr locus.
Similar articles
-
Genomic organization and chromosomal location of the mouse type I BMP-2/4 receptor.Biochem Biophys Res Commun. 1995 Jan 5;206(1):310-7. doi: 10.1006/bbrc.1995.1043. Biochem Biophys Res Commun. 1995. PMID: 7818535
-
Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene.Genomics. 1997 Dec 1;46(2):278-83. doi: 10.1006/geno.1997.5023. Genomics. 1997. PMID: 9417915
-
Genomic organization of a mouse type I activin receptor.Biochem Biophys Res Commun. 1995 Aug 4;213(1):211-7. doi: 10.1006/bbrc.1995.2118. Biochem Biophys Res Commun. 1995. PMID: 7639738
-
Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.Nat Struct Biol. 1999 Jan;6(1):18-22. doi: 10.1038/4887. Nat Struct Biol. 1999. PMID: 9886286 Review.
-
Molecular biology of MIS and its receptors.J Androl. 1996 Jul-Aug;17(4):336-41. J Androl. 1996. PMID: 8889695 Review.
Cited by
-
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.Gynecol Oncol. 2011 Jan;120(1):128-34. doi: 10.1016/j.ygyno.2010.09.017. Epub 2010 Nov 6. Gynecol Oncol. 2011. PMID: 21056908 Free PMC article.
-
Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.Cancer Immunol Immunother. 2008 Mar;57(3):367-78. doi: 10.1007/s00262-007-0376-2. Epub 2007 Aug 4. Cancer Immunol Immunother. 2008. PMID: 17676323 Free PMC article.
-
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.Future Oncol. 2010 Mar;6(3):391-405. doi: 10.2217/fon.09.172. Future Oncol. 2010. PMID: 20222796 Free PMC article. Review.
-
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors.Obstet Gynecol Sci. 2014 Sep;57(5):343-57. doi: 10.5468/ogs.2014.57.5.343. Epub 2014 Sep 17. Obstet Gynecol Sci. 2014. PMID: 25264524 Free PMC article. Review.
-
Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor II.J Immunol Res. 2015;2015:630287. doi: 10.1155/2015/630287. Epub 2015 Nov 5. J Immunol Res. 2015. PMID: 26618181 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases